ReviewMaterials (Basel, Switzerland)2025
Graphene Oxide: Preparation and Medical Research.
Review in Materials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- A Study of the Direct Effect of Pegylated Graphene Oxide Nanoparticles and Fullerenol CNanomaterials (Basel, Switzerland) · 2026Article
- Graphene Oxide-Modified Titanium Dioxide Nanotubes Promote Schwann Cell Function and Neurotrophic Factor Expression.Journal of functional biomaterials · 2026Article
- Modifying graphene oxide with magnetic nanoparticles and Mg-Al LDHs and its application as an efficient catalyst in organic reactions.Scientific reports · 2026Article
- Carbon-based nanomaterials in biomedicine and technology.Frontiers in chemistry · 2026Review
- Multifunctional GO-Based Hydrogels with Various Inorganic Additives for Oral Health and Photodynamic Activation.Gels (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Oxide (GO) has emerged as a highly versatile nanomaterial due to its exceptional physicochemical properties, including large surface area, and strong drug-loading capacity. These characteristics have enabled its broad application in fields such as wound healing, targeted drug delivery, and antimicrobial therapies. However, despite its promise, concerns surrounding GO's cytotoxicity, biocompatibility, and potential pathological effects have limited its clinical translation. Addressing these limitations requires a deeper understanding of GO's interactions with biological systems and the development of strategies to mitigate its adverse effects. Recent advances in surface functionalization, covalent crosslinking, and the incorporation of GO into biocompatible matrices have shown great potential in enhancing its performance while minimizing toxicity. This review provides a comprehensive overview of the antibacterial mechanisms of GO and highlights recent progress in chemical modification approaches that improve its efficacy in biomedical applications, particularly in wound healing and drug delivery. By critically examining both the advantages and limitations of GO, this work aims to inform future research directions and support the safe and effective integration of GO-based materials in advanced therapeutic systems.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.